BeOne Medicines (ONC) Net Equity Issued and Repurchased (2020 - 2021)
BeOne Medicines (ONC) posted quarterly Net Equity Issued and Repurchased of $50000.0 for Q3 2021, down 100.0% year-over-year from $2.1 billion in Q3 2020, and down 100.0% quarter-over-quarter from $2.1 billion in Q3 2020.
BeOne Medicines (ONC) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
BeOne Medicines (ONC) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $50000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Net Equity Issued and Repurchased fell 100.0% year-over-year to $50000.0; the TTM figure through Dec 2022 stood at $50000.0 (changed 0.0% YoY), while the FY2021 annual figure was $50.0 million, down 98.82% from the prior year.
- Net Equity Issued and Repurchased fell to $50000.0 in Q3 2021 per ONC's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $2.2 billion in Q1 2020 and bottomed at $50000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 50,000.00 |
| Sep 30, 2021 | 50,000.00 |
| Sep 30, 2020 | 2.07 Bn |
| Sep 30, 2020 | 2.07 Bn |
| Mar 31, 2020 | 2.16 Bn |
| Mar 31, 2020 | 2.16 Bn |